Expanding spectrum of prion diseases
Expanding spectrum of prion diseases
复制标题
DOI:
10.1042/etls20200037
复制
发表时间:
2020-09-01
影响因子:
3.8
通讯作者:
Prusiner, Stanley B.
中科院分区:
文献类型:
--
作者:
Ayers, Jacob, I;Paras, Nick A.;Prusiner, Stanley B.
Prions were initially discovered in studies of scrapie, a transmissible neurodegenerative disease (ND) of sheep and goats thought to be caused by slow viruses. Once scrapie was transmitted to rodents, it was discovered that the scrapie pathogen resisted inactivation by procedures that modify nucleic acids. Eventually, this novel pathogen proved to be a protein of 209 amino acids, which is encoded by a chromosomal gene. After the absence of a nucleic acid within the scrapie agent was established, the mechanism of infectivity posed a conundrum and eliminated a hypothetical virus. Subsequently, the infectious scrapie prion protein (PrPSc) enriched for beta-sheet was found to be generated from the cellular prion protein (PrPC) that is predominantly alpha-helical. The post-translational process that features in nascent prion formation involves a templated conformational change in PrPC that results in an infectious copy of PrPSc. Thus, prions are proteins that adopt alternative conformations, which are self-propagating and found in organisms ranging from yeast to humans. Prions have been found in both Alzheimer's (AD) and Parkinson's (PD) diseases. Mutations in APP and alpha-synuclein genes have been shown to cause familial AD and PD. Recently, AD was found to be a double prion disorder: both A beta and tau prions feature in this ND. Increasing evidence argues for alpha-synuclein prions as the cause of PD, multiple system atrophy, and Lewy body dementia.